These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6124209)

  • 1. The pharmacokinetic, pharmacodynamic and haemodynamic effects of acute and chronic alpha-adrenoceptor blockade in chronic heart failure.
    Taylor SH; Silke B
    Ann Acad Med Singap; 1981 Oct; 10(4 Suppl):45-51. PubMed ID: 6124209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate and sustained haemodynamic effects of prazosin during upright exercise in man.
    Silke B; Hendry WG; Taylor SH
    Br Heart J; 1981 Dec; 46(6):663-70. PubMed ID: 7317235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic effects of prazosin in CHF.
    Reuben SR; Kuan P; Gale EV; Wilde PM
    Acta Med Scand Suppl; 1981; 652():145-8. PubMed ID: 6949460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-adrenergic receptor blockade with prazosin. Consideration of hypertension, heart failure, and potential new applications.
    Colucci WS
    Ann Intern Med; 1982 Jul; 97(1):67-77. PubMed ID: 6124197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the renin-angiotensin system in the development of hemodynamic and clinical tolerance to long-term prazosin therapy in patients with severe chronic heart failure.
    Packer M; Medina N; Yushak M
    J Am Coll Cardiol; 1986 Mar; 7(3):671-80. PubMed ID: 2869077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and chronic haemodynamic effects of prazosin in left ventricular failure.
    Stein L; Foster PR; Friedman AW; Statza J; McHenry PL
    Br Heart J; 1981 Feb; 45(2):186-92. PubMed ID: 7459177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic studies with prazosin in chronic heart failure.
    Silke B; Lakhani ZM; Taylor SH
    J Cardiovasc Pharmacol; 1981; 3(2):329-35. PubMed ID: 6166804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of ibopamine plus prazosin in congestive heart failure.
    Naidoo DP; Rocke A; Mitha AS
    S Afr Med J; 1998 Feb; 88 Suppl 1():C25-31. PubMed ID: 9542492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic effects of a single low dose of prazosin in patients with chronic congestive cardiac failure correlations with pharmacokinetics.
    Horowitz JD; Dynon MK; Jarrott B; Brennan JB; Oliver LE; Goble AJ; Louis WJ
    Clin Exp Pharmacol Physiol; 1984; 11(1):7-15. PubMed ID: 6713738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of prazosin effect on cardiac output in chronic heart failure.
    Arnold SB; Williams RL; Ports TA; Baughman RA; Benet LZ; Parmley WW; Chatterjee K
    Ann Intern Med; 1979 Sep; 91(3):345-9. PubMed ID: 475164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prazosin in the treatment of severe chronic congestive cardiac failure.
    Hockings BE; Cope GD; Clarke GM; Taylor RR
    Aust N Z J Med; 1980 Aug; 10(4):420-5. PubMed ID: 6932833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic effects of sustained treatment with prazosin and metoprolol, alone and in combination, in borderline hypertensive heart failure.
    Nelson GI; Donnelly GL; Hunyor SN
    J Cardiovasc Pharmacol; 1982; 4(2):240-5. PubMed ID: 6175807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure.
    Harper RW; Claxton H; Middlebrook K; Anderson S; Pitt A
    Med J Aust; 1980 Jul; 2(SP1):36-8. PubMed ID: 7421721
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
    Desch CE; Magorien RD; Triffon DW; Blanford MF; Unverferth DV; Leier CV
    Am J Cardiol; 1979 Nov; 44(6):1178-82. PubMed ID: 495512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise.
    Bayliss J; Canepa-Anson R; Norell MS; Poole-Wilson P; Sutton G
    Br Heart J; 1986 Mar; 55(3):265-73. PubMed ID: 3513808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vasodilator therapy with alpha-receptor blockaders. Acute and chronic effect of prazosin and phentolamine in congestive heart failure].
    Kersting F; Samosny G; Kasper W; Schuster HP
    Med Welt; 1981 Jun; 32(26):1040-5. PubMed ID: 6114383
    [No Abstract]   [Full Text] [Related]  

  • 17. Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure.
    Rubin SA; Chatterjee K; Gelberg HJ; Ports TA; Brundage BH; Parmley WW
    Am J Cardiol; 1979 Apr; 43(4):810-5. PubMed ID: 425918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Orally active vasodilators in the management of chronic treatment-resistant cardiac failure (author's transl)].
    Wirtzfeld A; Klein G; Himmler FC; Schmidt G; Kutschera I; Sauer E
    Dtsch Med Wochenschr; 1980 Oct; 105(40):1379-83. PubMed ID: 7449633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term therapy with oral prazosin in chronic congestive heart failure: a clinical and echocardiographic evaluation (author's transl)].
    Sparvieri F; Cesari GP; Soro A
    G Ital Cardiol; 1980; 10(6):730-40. PubMed ID: 6780400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and chronic cardiocirculatory effects of oral prazosin in chronic refractory heart failure.
    Hayashi H; Sassa H; Oba M; Fukaya T; Okubo M; Niwa T; Matsui E
    Jpn Heart J; 1980 Nov; 21(6):827-36. PubMed ID: 7007686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.